Author/Authors :
Aguiar, Pablo Nuclear Medicine Dept. - Health Research Institute of Santiago de Compostela (IDIS) - Santiago de Compostela, Spain , Fernandez-Ferreiro, Anxo Health Research Institute of Santiago de Compostela (IDIS) - Santiago de Compostela, Spain , Galli, Filippo Faculty of Medicine and Psychology - Department of Medical-Surgical Sciences and Translational Medicine - “Sapienza” University - Roma, Italy , Tsoumpas, Charalampos Biomedical Imaging Science Department - Leeds Institute of Cardiovascular and Metabolic Medicine - School of Medicine - University of Leeds - Leeds, UK
Abstract :
Preclinical molecular imaging has become an essential tool
in translating the scienti c understanding that has been
gained by studying and developing the animal models of
multiple human diseases to the clinic. Today, several of
the current clinical imaging techniques are already available
for use in preclinical imaging models. It has allowed that
same parameters can be derived from preclinical and clinical
images, which has meant a swift translational trajectory for
many clinical trials in oncology, neurology or in-
flammation, or cardiology.
